Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / BCTX - BriaCell partners with Waisman Biomanufacturing to make & supply prostate cancer therapy


BCTX - BriaCell partners with Waisman Biomanufacturing to make & supply prostate cancer therapy

  • BriaCell Therapeutics ( NASDAQ: BCTX ) on Tuesday said it had entered into an agreement with Waisman Biomanufacturing for Waisman to make BCTX's prostate cancer therapy Bria-Pros.
  • Waisman Biomanufacturing is a contract manufacturing organization at the University of Wisconsin-Madison.
  • Waisman will make Bria-Pros for the anticipated use in clinical trials.
  • BCTX stock +3.1% to $6.27 in early trading.

For further details see:

BriaCell partners with Waisman Biomanufacturing to make & supply prostate cancer therapy
Stock Information

Company Name: BriaCell Therapeutics Corp.
Stock Symbol: BCTX
Market: NASDAQ
Website: briacell.com

Menu

BCTX BCTX Quote BCTX Short BCTX News BCTX Articles BCTX Message Board
Get BCTX Alerts

News, Short Squeeze, Breakout and More Instantly...